Documenting informed consent for treatment with neuroleptics: An alternative to the consent form

Psychiatric Services

Volumn 47, Issue 3, 1996, Pages 302-303

  Munetz, Mark R ^a,b   Peterson, Gregory A ^b,c  

^a Summit County Alcohol   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c Director of Nutrition Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL PRACTICE; ETHICS; INFORMED CONSENT; LAW; LEGAL ASPECT; MEDICAL DOCUMENTATION; MEDICAL RECORD; MENTAL DISEASE; PATIENT EDUCATION; PRESCRIPTION; RISK MANAGEMENT;

EID: 0029961675     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.47.3.302     Document Type: Article

References (8)

1. Tardive Dyskinesia: Report of the American Psychiatric Association Task Force on Late Neurological Effects of Antipsychotic Drugs. Washington, DC, American Psychiatric Association, 1980
2. Tardive Dyskinesia. A Task Force Report of the American Psychiatric Association. Washington, DC, American Psychiatric Association, 1992
3. Gutheil TG, Bursztajn HJ, Brodsky A, et al Decision Making in Psychiatry and the Law. Baltimore, Williams & Wilkins, 1991
4. Munetz MR, Roth LH: Informing patients about tardive dyskinesia. Archives of General Psychiatry 42.866-871, 1985
5. Klemman I, Schachter D, Jeffries J, et al: Effectiveness of two methods for informing patients about neuroleptic medication Hospital and Community Psychiatry 44:1189-1191, 1993
6. Benjamin S, Munetz MR. CMHC practices related to tardive dysldnesia screening and informed consent for neuroleptic drugs. Hospital and Community Psychiatry 45: 343-346, 1994
7. Administrative Rules, 5122-29-05(J). Columbus, Ohio Department of Mental Health, Jan 1, 1991
8. Appelbaum PS, Lidz CW, Meisel A. Informed Consent: Legal Theory and Clinical Practice New York, Oxford University Press, 1987